Additionally, intraprostatic injection of pCX-Shh-IG-GFP vectors in mice, resulting in persistent Shh ligand overexpression in adult prostates, leads to the development of invasive and metastatic prostate cancers within 90 days [136]. Here, SHH is linked to metastatic prostate carcinoma.